These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22345679)

  • 1. Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry.
    Damen NL; Pelle AJ; Boersma E; Serruys PW; van Domburg RT; Pedersen SS
    Eur J Prev Cardiol; 2013 Feb; 20(1):127-34. PubMed ID: 22345679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry.
    Damen NL; Versteeg H; Boersma E; Serruys PW; van Geuns RJ; Denollet J; van Domburg RT; Pedersen SS
    Int J Cardiol; 2013 Sep; 167(6):2496-501. PubMed ID: 22560933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents.
    Denollet J; Pedersen SS; Daemen J; de Jaegere P; Serruys PW; van Domburg RT
    J Intern Med; 2008 Feb; 263(2):203-11. PubMed ID: 18069998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and anxiety symptoms as predictors of mortality in PCI patients at 10 years of follow-up.
    van Dijk MR; Utens EM; Dulfer K; Al-Qezweny MN; van Geuns RJ; Daemen J; van Domburg RT
    Eur J Prev Cardiol; 2016 Mar; 23(5):552-8. PubMed ID: 25665581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
    Farooq V; Serruys PW; Bourantas C; Vranckx P; Diletti R; Garcia Garcia HM; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; van Es GA; Steyerberg EW; Dawkins KD; Mohr FW; James S; Ståhle E
    Eur Heart J; 2012 Dec; 33(24):3105-13. PubMed ID: 23103663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox.
    Younge JO; Damen NL; van Domburg RT; Pedersen SS
    Int J Cardiol; 2013 Aug; 167(4):1154-8. PubMed ID: 22475846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention.
    Pedersen SS; Denollet J; van Gestel YR; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):203-9. PubMed ID: 18391649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
    Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
    Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.
    Ong AT; Serruys PW; Aoki J; Hoye A; van Mieghem CA; Rodriguez-Granillo GA; Valgimigli M; Sonnenschein K; Regar E; van der Ent M; de Jaegere PP; McFadden EP; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT
    J Am Coll Cardiol; 2005 Apr; 45(7):1135-41. PubMed ID: 15808774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
    Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
    Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries).
    Cheng JM; Onuma Y; Piazza N; Nuis RJ; Van Domburg RT; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1376-81. PubMed ID: 21059424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
    Kunadian V; Pugh A; Zaman AG; Qiu W
    Coron Artery Dis; 2012 Nov; 23(7):469-79. PubMed ID: 22960383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C
    Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting.
    Marcolino MS; Simsek C; de Boer SP; van Domburg RT; van Geuns RJ; de Jaegere P; Akkerhuis KM; Daemen J; Serruys PW; Boersma E
    EuroIntervention; 2012 Dec; 8(8):920-8. PubMed ID: 22709564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.